Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
Clinical trial NCT05234580 · COMPLETED
Trial details
- NCT number
- NCT05234580
- Sponsor
- Anhui Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2022-10-10
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.